Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-115459
Filing Date
2020-10-16
Accepted
2020-10-16 06:10:06
Documents
1
Period of Report
2020-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2033244d6_form4.html 4  
1 FORM 4 tm2033244d6_form4.xml 4 3890
  Complete submission text file 0001104659-20-115459.txt   5412
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8800 HSC PARKWAY BRYAN TX 77807
Business Address
Armstrong Linda Washington (Reporting) CIK: 0001825579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 201242741